Joseph  Ciaffoni net worth and biography

Joseph Ciaffoni Biography and Net Worth

Joseph J. Ciaffoni currently works at Indivior PLC, as Chief Executive Officer-Elect & Director. Mr. Ciaffoni also formerly worked at Collegium Pharmaceutical, Inc., as President & Chief Executive Officer in 2024, BioDelivery Sciences International, Inc., as President & Chief Executive Officer, Schering-Plough Corp., as Vice President-Sales from 2004 to 2008, Shionogi Pharma, Inc., as Chief Commercial Officer & Executive VP from 2008 to 2010, Endo International Plc, as President-US Branded Pharmaceuticals in 2016, Shionogi, Inc., as Chief Operating Officer & Executive VP from 2008 to 2010, and Biogen-Idec Pharmaceuticals, Inc., as Senior VP-Global Specialty Medicines Group from 2012 to 2016.

Mr. Ciaffoni received his undergraduate degree in 1993 from Rutgers State University of New Jersey and Masters Business Admin degree in 2000 from Rutgers State University of New Jersey.

What is Joseph Ciaffoni's net worth?

The estimated net worth of Joseph Ciaffoni is at least $7.37 million as of December 21st, 2023. Ciaffoni owns 275,000 shares of Collegium Pharmaceutical stock worth more than $7,367,250 as of April 27th. This net worth approximation does not reflect any other investments that Ciaffoni may own. Additionally, Ciaffoni receives a salary of $1,690,000.00 as CEO at Collegium Pharmaceutical. Learn More about Joseph Ciaffoni's net worth.

How old is Joseph Ciaffoni?

Ciaffoni is currently 52 years old. There are 4 older executives and no younger executives at Collegium Pharmaceutical. Learn More on Joseph Ciaffoni's age.

What is Joseph Ciaffoni's salary?

As the CEO of Collegium Pharmaceutical, Inc., Ciaffoni earns $1,690,000.00 per year. Learn More on Joseph Ciaffoni's salary.

How do I contact Joseph Ciaffoni?

The corporate mailing address for Ciaffoni and other Collegium Pharmaceutical executives is 100 Technology Center Drive, Stoughton MA, 02072. Collegium Pharmaceutical can also be reached via phone at (781) 713-3699 and via email at info@collegiumpharma.com. Learn More on Joseph Ciaffoni's contact information.

Has Joseph Ciaffoni been buying or selling shares of Collegium Pharmaceutical?

Joseph Ciaffoni has not been actively trading shares of Collegium Pharmaceutical over the course of the past ninety days. Most recently, Joseph Ciaffoni sold 4,357 shares of the business's stock in a transaction on Thursday, December 21st. The shares were sold at an average price of $30.38, for a transaction totalling $132,365.66. Following the completion of the sale, the chief executive officer now directly owns 275,000 shares of the company's stock, valued at $8,354,500. Learn More on Joseph Ciaffoni's trading history.

Who are Collegium Pharmaceutical's active insiders?

Collegium Pharmaceutical's insider roster includes Garen Bohlin (Director), Joseph Ciaffoni (CEO), Joseph Ciaffoni (Pres), Scott Dreyer (EVP), Michael Heffernan (Director), Shirley Kuhlmann (EVP), Thomas Smith (EVP), Colleen Tupper (CFO), and Colleen Tupper (Exec. VP & CFO ). Learn More on Collegium Pharmaceutical's active insiders.

Are insiders buying or selling shares of Collegium Pharmaceutical?

During the last year, insiders at the specialty pharmaceutical company sold shares 12 times. They sold a total of 243,536 shares worth more than $7,872,884.47. The most recent insider tranaction occured on March, 14th when CFO Colleen Tupper sold 977 shares worth more than $29,310.00. Insiders at Collegium Pharmaceutical own 2.5% of the company. Learn More about insider trades at Collegium Pharmaceutical.

Information on this page was last updated on 3/14/2025.

Joseph Ciaffoni Insider Trading History at Collegium Pharmaceutical

See Full Table

Joseph Ciaffoni Buying and Selling Activity at Collegium Pharmaceutical

This chart shows Joseph Ciaffoni's buying and selling at Collegium Pharmaceutical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$2M-$1M$0$1M$2MTotal Insider BuyingTotal Insider Selling

Collegium Pharmaceutical Company Overview

Collegium Pharmaceutical logo
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, and oral formulation of oxycodone for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; Belbuca, a buccal film that contains buprenorphine; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
Read More

Today's Range

Now: $26.79
Low: $26.22
High: $27.09

50 Day Range

MA: $28.40
Low: $24.67
High: $30.56

2 Week Range

Now: $26.79
Low: $23.23
High: $42.29

Volume

214,645 shs

Average Volume

444,130 shs

Market Capitalization

$860.82 million

P/E Ratio

11.55

Dividend Yield

N/A

Beta

0.76